Perspectives on technology: All STEPS count - an integrated framework for net zero urological care.

Hyde J, King E, John J, O'Flynn K, Pearce I, McGrath J, Gray WK, Phull M

Evaluating the management of intermittent claudication before and after publication of the Society of Vascular Surgery's Appropriate Use Criteria.

Alonso A, Kobzeva-Herzog A, Dalton-Petillo S, Haqqani M, Farber A, King EG, Hicks CW, Malas M, Garg K, Osborne N, Simons JP, Siracuse JJ

Cognitive dysfunction, psychiatric distress, and functional decline after liver transplantation.

Ruck JM, Murriel EC, Fortune Hernandez N, Jefferis AA, McAdams DeMarco M, Vannorsdall TD, Segev DL, King EA, Oh ES

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.

Gillessen S, Murphy L, James ND, Sachdeva A, El-Taji O, Abdel-Aty H, Adler AI, Amos C, Attard G, Varughese M, Gale J, Brown S, Srihari N, Birtle AJ, Brown M, Chan K, Chowdhury S, Cross W, Dearnaley DP, Din O, Dutey-Magni P, Gilbert DC, Gilson C, Gray S, Grist E, Hofmann U, Hudson AM, Jain Y, Jeyasangar G, Jones R, Kayani M, Langley RE, Malik Z, Mason MD, Matheson D, McAlpine C, Macnair A, Millman R, Murphy C, Padden-Modi M, Parikh O, Parker C, Rush H, Russell M, Srinivasan R, Sundar S, Tanguay JS, Turco F, Williams P, Sydes MR, Parmar MKB, Brown LC, Clarke NW, STAMPEDE investigators

Ecosystem accounting for biodiversity surrounding windfarms.

King E, Stout JC, Buckley YM, Donohue I

CAR-T cells containing CD28 versus 4-1BB co-stimulatory domains show distinct metabolic profiles in patients.

Cook MS, King E, Flaherty KR, Siddika K, Papa S, Benjamin R, Schurich A

Enhancing and leveraging principal investigator and patient advocacy group collaboration in rare disease clinical research-meeting report from the rare Diseases Clinical Research Network.

Wheeden K, Meyers S, Anthony K, Chehade M, Gifford RC, King EC, Seid M

Survival Benefit of Deceased Donor Kidney Transplantation among Patients with Peripheral Artery Disease.

Tan LT, Kernodle AB, Yu S, McDermott K, White M, Holscher CM, Lum YW, Segev DL, Massie AB, King EA, Black JH 3rd, Hicks CW

Transfection of bovine cells with synthetic mRNA to induce expression of functional antibodies against Tritrichomonas foetus surface antigen TF1.17.

Thoresen M, Vanover D, King EH, Sidelinger D, Feugang JM, Peck HE, McAtee K, Santangelo PJ, Woolums AR

Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial.

Luchsinger JA, Rosin SP, Kazemi EJ, Younes N, Suratt CE, Fattaleh BN, Florez HJ, Gonzalez JS, Hollander P, Hox SH, Kuo S, Lee MS, Martens T, Pop-Busui R, Seaquist ER, Waltje AH, Barzilay JI, GRADE Research Group

Self-reported HIV viral load is reliable and not affected by adverse lived experiences of women living with HIV in British Columbia.

Povshedna T, Swann SA, Silva MAP, Tognazzini S, Lee M, King EM, Osborne Z, Kaida A, Murray MCM, Côté HCF, British Columbia CARMA‐CHIWOS Collaboration (BCC3; CIHR CTN 335)

Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study.

Ehrmann D, Krause-Steinrauf H, Uschner D, Wen H, Hoogendoorn CJ, Crespo-Ramos G, Presley C, Arends VL, Cohen RM, Garvey WT, Martens T, Willis HJ, Cherrington A, Gonzalez JS, GRADE Research Group

Correction: Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study.

Ehrmann D, Krause-Steinrauf H, Uschner D, Wen H, Hoogendoorn CJ, Crespo-Ramos G, Presley C, Arends VL, Cohen RM, Garvey WT, Martens T, Willis HJ, Cherrington A, Gonzalez JS, GRADE Research Group

New kidney-after-heart allocation policy in the United States: Who would benefit from a rescue kidney?

Zhou AL, Akbar AF, Rizaldi AA, Ruck JM, Larson EL, Rokui S, Paneitz DC, King EA, Kilic A

Sensorimotor Dysfunction Following Anterior Cruciate Ligament Injury (Part 2): How Can Clinicians Rehabilitate It?

Vitharana TN, King E, Welch N, Devitt B, Moran K